BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29866066)

  • 1. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
    Xintaropoulou C; Ward C; Wise A; Queckborner S; Turnbull A; Michie CO; Williams ARW; Rye T; Gourley C; Langdon SP
    BMC Cancer; 2018 Jun; 18(1):636. PubMed ID: 29866066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.
    Xintaropoulou C; Ward C; Wise A; Marston H; Turnbull A; Langdon SP
    Oncotarget; 2015 Sep; 6(28):25677-95. PubMed ID: 26259240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
    Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
    Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
    Cho MH; Park CK; Park M; Kim WK; Cho A; Kim H
    PLoS One; 2015; 10(10):e0141413. PubMed ID: 26509967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1 regulates PKM2 function through Akt phosphorylation.
    Salani B; Ravera S; Amaro A; Salis A; Passalacqua M; Millo E; Damonte G; Marini C; Pfeffer U; Sambuceti G; Cordera R; Maggi D
    Cell Cycle; 2015; 14(10):1559-67. PubMed ID: 25790097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors.
    Sullivan EJ; Kurtoglu M; Brenneman R; Liu H; Lampidis TJ
    Cancer Chemother Pharmacol; 2014 Feb; 73(2):417-27. PubMed ID: 24352250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
    Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
    EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
    Loar P; Wahl H; Kshirsagar M; Gossner G; Griffith K; Liu JR
    Am J Obstet Gynecol; 2010 Apr; 202(4):371.e1-8. PubMed ID: 20138251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
    Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
    Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
    Yu M; Chen S; Hong W; Gu Y; Huang B; Lin Y; Zhou Y; Jin H; Deng Y; Tu L; Hou B; Jian Z
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):967-999. PubMed ID: 30825027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
    Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
    Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
    Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the glycolytic pathway and glycolysis related-genes in tumorigenesis of human colorectal cancers.
    Yeh CS; Wang JY; Chung FY; Lee SC; Huang MY; Kuo CW; Yang MJ; Lin SR
    Oncol Rep; 2008 Jan; 19(1):81-91. PubMed ID: 18097579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
    Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro.
    Wang K; Fan H; Chen Q; Ma G; Zhu M; Zhang X; Zhang Y; Yu J
    Anticancer Drugs; 2015 Jan; 26(1):15-24. PubMed ID: 25229889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
    Alkema NG; Wisman GB; van der Zee AG; van Vugt MA; de Jong S
    Drug Resist Updat; 2016 Jan; 24():55-69. PubMed ID: 26830315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.